Page 152 - Read Online

Chen et al. Hepatoma Res 2019;5:12 I http://dx.doi.org/10.20517/2394-5079.2019.03 Page 15 of 17

65. Bird TG, Dimitropoulou P, Turner RM, Jenks SJ, Cusack P, et al. Alpha-fetoprotein detection of hepatocellular carcinoma leads to a
standardized analysis of dynamic AFP to improve screening based detection. PLoS One 2016;11:e0156801.
66. Marrero JA, El-Serag HB. Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the
American Association for the Study of Liver Diseases. Hepatology 2011;53:1060-1; author reply 1061-2.
67. Chiang JK, Chih-Wen L, Kao YH. Effect of ultrasonography surveillance in patients with liver cancer: a population-based longitudinal
study. BMJ Open 2017;7:e015936.
68. Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients
with cirrhosis: a meta-analysis. PLoS Med 2014;11:e1001624.
69. Singal A, Volk ML, Waljee A, Salgia R, Higgins P, et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular
carcinoma in patients with cirrhosis. Aliment Pharmacol Ther 2009;30:37-47.
70. Sheu JC, Sung JL, Chen DS, Lai MY, Wang TH, et al. Early detection of hepatocellular carcinoma by real-time ultrasonography. A
prospective study. Cancer 1985;56:660-6.
71. Trinchet JC, Chaffaut C, Bourcier V, Degos F, Henrion J, et al. Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis:
a randomized trial comparing 3- and 6-month periodicities. Hepatology 2011;54:1987-97.
72. Chen TH, Chen CJ, Yen MF, Lu SN, Sun CA, et al. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a
high risk group in Taiwan. Int J Cancer 2002;98:257-61.
73. Siripongsakun S, Vidhyarkorn S, Charuswattanakul S, Mekraksakit P, Sungkasubun P, et al. Ultrasound surveillance for
cholangiocarcinoma in an endemic area: A prove of survival benefits. J Gastroenterol Hepatol 2018;33:1383-8.
74. Chaiteerakij R, Chattieng P, Choi J, Pinchareon N, Thanapirom K, et al. Surveillance for hepatocellular carcinoma reduces mortality:
an inverse probability of treatment weighted analysis. Ann Hepatol 2017;16:421-9.
75. Gannon CJ, Izzo F, Aloia TA, Pignata S, Nasti G, et al. Can hepatocellular cancer screening increase the proportion of long-term
survivors? Hepatogastroenterology 2009;56:1152-6.
76. McMahon BJ, Bulkow L, Harpster A, Snowball M, Lanier A, et al. Screening for hepatocellular carcinoma in Alaska natives infected
with chronic hepatitis B: a 16-year population-based study. Hepatology 2000;32:842-6.
77. Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, et al. Screening programme of cirrhotic patients for early diagnosis and treatment of
hepatocellular carcinoma: a cost-effectiveness analysis. Gut 2001;48:251-9.
78. Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, et al. Impact of surveillance on survival of patients with initial hepatocellular
carcinoma: a study from Japan. Clin Gastroenterol Hepatol 2006;4:1170-6.
79. Zhang B, Yang B. Combined alpha fetoprotein testing and ultrasonography as a surveillance test for primary liver cancer. J Med
Screen 1999;6:108-10.
80. Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, et al. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound
alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology 2009;137:110-8.
81. Chang CC, Chen HH, Chang YC, Yang MY, Lo CM, et al. Computer-aided diagnosis of liver tumors on computed tomography
images. Comput Methods Programs Biomed 2017;145:45-51.
82. Sastre J, Díaz-Beveridge R, García-Foncillas J, Guardeño R, López C, et al. Clinical guideline SEOM: hepatocellular carcinoma. Clin
Transl Oncol 2015;17:988-95.
83. Pocha C, Dieperink E, McMaken KA, Knott A, Thuras P, et al. Surveillance for hepatocellular cancer with ultrasonography vs.
computed tomography-a randomised study. Aliment Pharmacol Ther 2013;38:303-12.
84. Fukugawa Y, Namimoto T, Toya R, Saito T, Yuki H, et al. Radiation-induced liver injury after 3D-conformal radiotherapy for
hepatocellular carcinoma: quantitative assessment using Gd-EOB-DTPA-enhanced MRI. Acta Med Okayama 2017;71:25-9.
85. Braillon A. Hepatocellular Carcinoma Screening: Seeking Robust Evidence. Gastroenterology 2019;156:288-9.
86. Gounder PP, Bulkow LR, Meltzer MI, Bruce MG, Hennessy TW, et al. Cost-effectiveness analysis of hepatocellular carcinoma
screening by combinations of ultrasound and alpha-fetoprotein among Alaska native people, 1983-2012. Int J Circumpolar Health
2016;75:31115.
87. Sarkar M, Stewart S, Yu A, Chen MS, Nguyen TT, et al. Hepatocellular carcinoma screening practices and impact on survival among
hepatitis B-infected Asian Americans. J Viral Hepat 2012;19:594-600.
88. Tong MJ, Sun HE, Hsien C, Lu DS. Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with
hepatitis B: results from a community-based clinic. Dig Dis Sci 2010;55:826-35.
89. Hong TP, Gow PJ, Fink M, Dev A, Roberts SK, et al. Surveillance improves survival of patients with hepatocellular carcinoma: a
prospective population-based study. Med J Aust 2018;209:348-54.
90. Chen JG, Zhang BC, Lu JH, Chen QG, Yun ZX, et al. Review in progress of liver cancer screening in Qidong. China Cancer
1996;5:11-3. (in Chinese)
91. Chen JG. Survival analysis of 5380 registered patients with liver cancer. Chin J Cancer 1984;3:254-7. (in Chinese)
92. Yang BH, Liu KD, Tang ZY. Prelimary analysis of liver cancer screening in high risk population. Tumor 1987;7:82-3. (in Chinese)
93. Chen JG, Zhang BC, Jiang YH, Wang MR, Lu JH, et al. Studdy on screening for PLC in high risk population of an endemic area. Chin
J Prev Med 1991;25:325-8. (in Chinese)
94. Zhou XP, Chen QG, Yun ZX, Shen QJ, Zhang H, et al. Determination of screening interval for liver cancer: a nested case-control
study. J Nanjing Railw Med College 1996;15:226-8. (in Chinese)
95. Dong ZW, Qiao YL. The practice and discussion of population-based cancer screening program in China. China Cancer 2009;19:686-
9. (in Chinese)
96. Dong ZW. Chinese technical protocols for early diagnosis and treatment of cancer. 1st ed. Beijing: People’s Medical Publishing
House. 2009; pp. 154-84. (in Chinese)
97. Chen JG, Zhang YH, Zhu J, Lu JH, Wang JB, et al. Early diagnosis and early treatment of liver cancer in Qidong: survival of patients